Skip to main content

Table 1 Comparison of PSA, PCA3 and TMPRSS2:ERG mRNA copy levels in CTC enriched fractions from androgen-dependent prostate cancer patients.

From: Molecular assays for the detection of prostate tumor derived nucleic acids in peripheral blood

Patient #

PSA

PCA3

TMPRSS2: ERG

1

-

-

N/A

2

-

-

N/A

3

-

-

N/A

4

154,893

-

-

5

-

-

-

6

-

-

-

7

-

-

-

8

-

-

-

9

-

-

-

10

66

-

-

11

1,928

-

+

12

-

-

-

13

-

-

-

14

-

-

-

15

-

-

-

16

-

-

-

17

-

-

-

  1. Blood samples from prostate cancer patients were processed using the dual antibody (anti-PSMA plus anti-EpCAM) magnetic particle formulation. CTC enriched fractions were prepared from patients diagnosed with advanced androgen-dependent prostate cancer (n = 17). N/A = insufficient sample available for measurement.